201 Tresser Boulevard
Stamford, CT 06901
Greenfield BioVentures combines decades of global pharmaceutical rigor with entrepreneurial creativity in early-stage investing. Our goal is accelerated value-inflection for promising therapeutic programs.
WE’RE LOOKING FOR THE NEXT GENERATION OF MEDICINES
We offer a creative blend of financing, experience and networks, and in some cases, operational bandwidth to support aspects of a development plan.
The defining characteristic of our investment thesis is value-inflection in early stages of clinical development. We’re always looking for that creative experiment that reduces scientific risk early in the research process. Our goal is to double or triple the probability-of-success of an asset in the eyes of seasoned biopharmaceutical investors, within 12-24 months from investment.
We are a subsidiary of Purdue Pharmaceuticals LP.